In vivo photoacoustic imaging of chemotherapy-induced apoptosis in squamous cell carcinoma using a near-infrared caspase-9 probe

View/ Open
Issue Date
2011-10-27Author
Yang, Qiuhong
Cui, Huizhong
Cai, Shuang
Yang, Xinmai
Forrest, M. Laird
Publisher
Society of Photo-optical Instrumentation Engineers (SPIE)
Type
Article
Article Version
Scholarly/refereed, publisher version
Metadata
Show full item recordAbstract
Anti-cancer drugs typically exert their pharmacological effect on tumors by inducing apoptosis, or programmed cell death, within the cancer cells. However, no tools exist in the clinic for detecting apoptosis in real time. Microscopic examination of surgical biopsies and secondary responses, such as morphological changes, are used to verify efficacy of a treatment. Here, we developed a novel near-infrared dye-based imaging probe to directly detect apoptosis with high specificity in cancer cells by utilizing a noninvasive photoacoustic imaging (PAI) technique. Nude mice bearing head and neck tumors received cisplatin chemotherapy (10 mg/kg) and were imaged by PAI after tail vein injection of the contrast agent. In vivo PAI indicated a strong apoptotic response to chemotherapy on the peripheral margins of tumors, whereas untreated controls showed no contrast enhancement by PAI. The apoptotic status of the mouse tumor tissue was verified by immunohistochemical techniques staining for cleaved caspase-3 p11 subunit. The results demonstrated the potential of this imaging probe to guide the evaluation of chemotherapy treatment.
Description
This is the published version. Copyright 2011 Society of Photo-optical Instrumentation Engineers (SPIE)
Collections
Citation
Yang, Qiuhong, Huizhong Cui, Shuang Cai, Xinmai Yang, and M. Laird Forrest. "In Vivo Photoacoustic Imaging of Chemotherapy-induced Apoptosis in Squamous Cell Carcinoma Using a Near-infrared Caspase-9 Probe." J. Biomed. Opt. Journal of Biomedical Optics 16.11 (2011): 116026. http://dx.doi.org/10.1117/1.3650240
Items in KU ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
We want to hear from you! Please share your stories about how Open Access to this item benefits YOU.